Larvol Delta - Clearside-Biomedical-Announces-Successful-EndofPhase-2-Meeting-with-the-FDA-and-Alignment-on-Phase-3-Plans-for-Suprachoroidal-CLSAX-in-Wet-AMD

axitinib injectable suspension (CLS-AX) - Clearside Biomedical

https://www.globenewswire.com/news-release/2025/03/06/3038074/0/en/Clearside-Biomedical-Announces-Successful-End-of-Phase-2-Meeting-with-the-FDA-and-Alignment-on-Phase-3-Plans-for-Suprachoroidal-CLS-AX-in-Wet-AMD.html

Mar 6, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next